New U.S. rules aim to cut antibiotic use in farm animals
(Reuters) - U.S. regulators announced new guidelines on Wednesday to phase out the use of antibiotics as a growth enhancer in livestock, in an effort to stem a surge in...
All Stories
New U.S. rules aim to cut antibiotic use in farm animals
(Reuters) - U.S. regulators announced new guidelines on Wednesday to phase out the use of antibiotics as a growth enhancer in livestock, in an effort to stem a surge in...
FDA lifts constraints on Glaxo diabetes drug Avandia
(Reuters) - Health regulators said on Monday they would lift restrictions on the use of GlaxoSmithKline Plc's once widely prescribed diabetes drug Avandia, after determining that it did not increase...
Amgen cholesterol drug appears safe, cut LDL 52 percent at 1 year: study
DALLAS (Reuters) - Amgen Inc's experimental heart medicine from a closely watched new class of drugs called PCSK9 inhibitors lowered "bad" LDL cholesterol 52 percent after one year with no...
Gene analysis fails to help predict best warfarin dose
(Reuters) - Gene analysis failed in a U.S. clinical trial to help doctors select better doses of warfarin, the widely used blood-thinner, which can cause dangerous bleeding if doses are...
Signs of ‘sudden’ cardiac death may come weeks before: study
(Reuters) - Signs of approaching "sudden" cardiac arrest, an electrical malfunction that stops the heart, usually appear at least a month ahead of time, according to a study of middle-age...
Heart guidelines authors defend method of calculating risk
Dallas (Reuters) - Top cardiologists who devised new U.S. guidelines for reducing risk of heart disease strenuously defended their risk-calculation tool from criticism that it greatly overestimates health risks and...
Pfizer third-quarter profit beats estimates, oncology drugs shine
(Reuters) - Pfizer Inc reported better-than-expected third-quarter earnings on Tuesday, helped by cuts in costs and growing sales of cancer medicines approved over the past two years. The largest U.S....
Regeneron, Sanofi drug slashes cholesterol in late-stage trial
(Reuters) - A new type of cholesterol drug being developed by Regeneron Pharmaceuticals Inc and Sanofi SA, when used by itself, cut levels of "bad" LDL cholesterol almost in half...
Regeneron, Sanofi drug slashes cholesterol in late-stage trial
(Reuters) - A new type of cholesterol drug being developed by Regeneron Pharmaceuticals Inc and Sanofi SA, when used by itself, cut levels of "bad" LDL cholesterol almost in half...